高级检索
    胡夕春, 顾史洋, 祖健. 21基因复发风险评分与淋巴结阴性、激素受体阳性乳腺癌局部复发的关系[J]. 循证医学, 2010, 10(2): 77-79. DOI: 10.3969/j.issn.1671-5144.2010.02.010
    引用本文: 胡夕春, 顾史洋, 祖健. 21基因复发风险评分与淋巴结阴性、激素受体阳性乳腺癌局部复发的关系[J]. 循证医学, 2010, 10(2): 77-79. DOI: 10.3969/j.issn.1671-5144.2010.02.010
    shu
    Hu Xi-chun, GU Shi-yang, ZU Jian. Association between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 77-79. DOI: 10.3969/j.issn.1671-5144.2010.02.010
    Citation: Hu Xi-chun, GU Shi-yang, ZU Jian. Association between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 77-79. DOI: 10.3969/j.issn.1671-5144.2010.02.010
    shu

    21基因复发风险评分与淋巴结阴性、激素受体阳性乳腺癌局部复发的关系

    Association between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回